Correlation Between Dogwood Therapeutics, and Eupraxia Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Dogwood Therapeutics, and Eupraxia Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dogwood Therapeutics, and Eupraxia Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Dogwood Therapeutics, and Eupraxia Pharmaceuticals Common, you can compare the effects of market volatilities on Dogwood Therapeutics, and Eupraxia Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dogwood Therapeutics, with a short position of Eupraxia Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dogwood Therapeutics, and Eupraxia Pharmaceuticals.

Diversification Opportunities for Dogwood Therapeutics, and Eupraxia Pharmaceuticals

-0.47

Correlation Coefficient

Dogwood Therapeutics,  Eupraxia Pharmaceuticals

Very good diversification

The 3 months correlation between Dogwood and Eupraxia is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Dogwood Therapeutics, and Eupraxia Pharmaceuticals Commo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eupraxia Pharmaceuticals and Dogwood Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dogwood Therapeutics, are associated (or correlated) with Eupraxia Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eupraxia Pharmaceuticals has no effect on the direction of Dogwood Therapeutics, i.e., Dogwood Therapeutics, and Eupraxia Pharmaceuticals go up and down completely randomly.

Pair Corralation between Dogwood Therapeutics, and Eupraxia Pharmaceuticals

Given the investment horizon of 90 days Dogwood Therapeutics, is expected to under-perform the Eupraxia Pharmaceuticals. In addition to that, Dogwood Therapeutics, is 1.71 times more volatile than Eupraxia Pharmaceuticals Common. It trades about -0.09 of its total potential returns per unit of risk. Eupraxia Pharmaceuticals Common is currently generating about 0.22 per unit of volatility. If you would invest  250.00  in Eupraxia Pharmaceuticals Common on August 31, 2024 and sell it today you would earn a total of  95.00  from holding Eupraxia Pharmaceuticals Common or generate 38.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	95.65%
Values	Daily Returns

Dogwood Therapeutics,  vs.  Eupraxia Pharmaceuticals Commo

Dogwood Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Dogwood Therapeutics, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Eupraxia Pharmaceuticals

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Eupraxia Pharmaceuticals Common are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Eupraxia Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Dogwood Therapeutics, and Eupraxia Pharmaceuticals

The main advantage of trading using opposite Dogwood Therapeutics, and Eupraxia Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dogwood Therapeutics, position performs unexpectedly, Eupraxia Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eupraxia Pharmaceuticals will offset losses from the drop in Eupraxia Pharmaceuticals' long position.

The idea behind Dogwood Therapeutics, and Eupraxia Pharmaceuticals Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.